Two transgenic approaches to define the cell lineages in endocrine pancreas development
- 1 May 1998
- journal article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 140 (1-2), 45-50
- https://doi.org/10.1016/s0303-7207(98)00028-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Phenotypic alterations in insulin-deficient mutant miceProceedings of the National Academy of Sciences of the United States of America, 1997
- Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cellsNature, 1997
- The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient miceDevelopment, 1996
- Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes.Proceedings of the National Academy of Sciences, 1994
- Insulin-promoter-factor 1 is required for pancreas development in miceNature, 1994
- Knockout Mice: Round TwoScience, 1994
- Targeted ablation of α-crystalIin-synthesizing cells produces lens-deficient eyes in transgenic miceDevelopment, 1989
- Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neuronsCell, 1988
- Dwarf mice produced by genetic ablation of growth hormone-expressing cells.Genes & Development, 1988
- Genetic Ablation: Targeted Expression of a Toxin Gene Causes Microphthalmia in Transgenic MiceScience, 1987